Pulmonary Perspectives®
Pulmonary Perspectives®
Pseudomonas infection in patients with noncystic fibrosis bronchiectasis
Pseudomonas aeruginosa is a clinically important organism that infects patients with noncystic fibrosis bronchiectasis (NCFB).
Pulmonary Perspectives®
Changing the tumor board conversation: Immunotherapy in resectable NSCLC
Immunotherapy has transformed the treatment landscape of NSCLC and enhanced survival rates.
Pulmonary Perspectives®
Are Beta-Blockers Safe for COPD?
A COPD with comorbid CV disease RCT is unlikely, says physician, though benefit of stopping beta-blockers is unclear.
Pulmonary Perspectives®
Military burn pits: Their evidence and implications for respiratory health
Military professionals face respiratory health risks from burn pits while on deployments.
Pulmonary Perspectives®
Managing severe asthma exacerbations in the ED: We need answers beyond albuterol
Treatment guidance for severe exacerbations of asthma in the ED is lacking.
Pulmonary Perspectives®
Obesity and lung disease in the era of GLP-1 agonists
Now is the time for pulmonary clinicians to become comfortable counseling patients about and treating obesity.
Pulmonary Perspectives®
The double-edged sword of virtual pulmonary rehabilitation
Virtual PR can alleviate access issues while in-person connection, motivation lacking.
Pulmonary Perspectives®
Home oxygen therapy: What does the data show?
Chronic obstructive pulmonary disease is the most common reason for the prescription of long-term oxygen therapy.
Pulmonary Perspectives®
Which biologic therapy should I use in patients who have moderate to severe asthma with associated comorbidities?
As new treatments for specific moderate to severe asthma phenotypes have been developed, management decisions have grown more complicated.
Pulmonary Perspectives®
Cardiopulmonary exercise testing for unexplained dyspnea
Unexplained dyspnea is a common complaint among patients seen in pulmonary clinics, and can be difficult to define.